Legal status of methamphetamine

From WikiMD's WELLNESSPEDIA

Legal status of methamphetamine is a topic that pertains to the laws and regulations surrounding the use, possession, and distribution of methamphetamine, a powerful and highly addictive stimulant drug. The legal status of methamphetamine varies widely across different countries and jurisdictions, reflecting differing societal attitudes towards drug use and differing approaches to drug control policy.

Overview[edit]

Methamphetamine is a synthetic drug with more rapid and lasting effects than amphetamine, used illegally as a stimulant and as a prescription drug to treat narcolepsy and maintain blood pressure. In many jurisdictions, methamphetamine is classified as a controlled substance, which means that its manufacture, distribution, and use are subject to strict legal controls.

Legal status by country[edit]

United States[edit]

In the United States, methamphetamine is classified as a Schedule II controlled substance under the Controlled Substances Act. This means that while the drug has a high potential for abuse and dependency, it also has accepted medical uses and can be prescribed by a doctor under certain circumstances. However, the non-medical use, possession, or distribution of methamphetamine is a criminal offense.

United Kingdom[edit]

In the United Kingdom, methamphetamine is classified as a Class A drug under the Misuse of Drugs Act 1971. This is the highest classification, reserved for drugs that are considered to have a high potential for abuse and no accepted medical use. Possession, distribution, or production of methamphetamine is a criminal offense.

Australia[edit]

In Australia, methamphetamine is classified as a Schedule 8 controlled drug under the Poisons Standard. This means that it is a controlled drug, the use of which is subject to strict legal controls. Possession, distribution, or manufacture of methamphetamine without a license is a criminal offense.

See also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.